Nature Medicine, Published online: 25 June 2025; doi:10.1038/s41591-025-03740-5
A new study identifies a novel subset of mast cells that cross-present tumor antigens in patients triple-negative breast cancer — and a pilot clinical trial shows how these can be exploited in immunotherapy strategies.
